The global veterinary antimicrobial susceptibility testing market size was USD 40.5 Billion in 2022 and is likely to reach USD 73.98 Billion by 2031, expanding at a CAGR of 7.1% during 2023–2031. The market is propelled by the growing awareness of animal welfare and medicine.
Rise in the number of veterinary practitioners and high demand for animal-derived products is expected to boost the market during the assessment period. The emerging danger of antimicrobial resistance caused by the excessive use of antibiotics and the increasing prevalence of zoonotic diseases is substantially raising the requirement for an intensive antimicrobial susceptibility testing market. this rising need for veterinary antimicrobial susceptibility testing is projected to propel the market in the coming years.
-
According to the National Agricultural Statistics Service report published by the United States Department of Agriculture in January 2023, as of 1 January 2023, there are close to 28.9 million beef cows. Furthermore, the calf crop had an estimation of 28.9 million beef cows.
Different microbial treatments are required to treat various bacterial diseases in animals. With the rising number of pet owners, the requirement for pet insurance is increasing. To ensure the proper health of pet animals, veterinary antimicrobial susceptibility testing is required to select the best antimicrobial agent for the treatment of animals. Furthermore, the surging demand for livestock products is leading to high consumption of antimicrobial drugs, which is likely to boost the market in the coming years.
The research report finds that the COVID-19 pandemic hindered the market, due to the restricted supply chain caused by lockdowns that were imposed by various governments all across the globe. Besides, the demand for veterinary antimicrobial susceptibility testing decreased as COVID had no significant impact on animals and all the healthcare resources were diverted towards the medical treatment of humans. As things are now getting better, the market is projected to have considerable growth during the forecast period.
Impact of Artificial Intelligence (AI) on the Veterinary Antimicrobial Susceptibility Testing Market
Emergence of artificial intelligence is likely to provide a substantial boost to the veterinary antimicrobial susceptibility testing market. It is used for a wide variety of objectives, including surveillance, clinical care, drug development, and identification of new antimicrobial resistance (AMR) drugs. Furthermore, the use of AMR prediction models that are based on personalized machine learning (ML) is anticipated to provide favorable conditions for its rapid adoption.
Veterinary Antimicrobial Susceptibility Testing Market Dynamics
Major Drivers
Rising danger of antimicrobial resistance is expected to drive the market during the projection period. The overuse of antibiotics and antimicrobials in livestock products, particularly in the swine and poultry sectors, has led to the threat of resistance towards these drugs in bacteria. The easy availability of antimicrobial drugs for feed suppliers is one of the primary reasons for their overuse. As a result, in order to ensure the effectiveness of the drugs, the quantity given to animals is increasing and is expected to impel the market during the forecast period.
-
As per the report published by the US Foods and Drugs Administration in December 2022, it is estimated that approximately 80% of the antibiotics sold in the United States are generally used for livestock. The rate of metabolism for various drugs is different for each animal, due to which, they may require longer administration of those drugs.
Existing Restraints
High cost of automated testing systems is likely to hamper the market during the forecast period. The traditional veterinary antimicrobial susceptibility testing methods such as micro-broth dilution, chromogenic agar method, agar dilution, and disc diffusion require 24-48 hours to give the results. This is hampering the growth of the market.
The use of automated antimicrobial susceptibility testing systems takes less time. Further, it improves accuracy by reducing the chances of human errors. However, the apparatus required for automated testing is extremely expensive, and therefore, often inaccessible to a large number of veterinary laboratories, especially in developing economies. This is expected to impede the market in the coming years.
Emerging Opportunities
Upsurge in supportive initiatives by various governments is anticipated to provide substantial growth opportunities for the market. Emerging economies such as India and China have livestock markets that are developing at a rapid pace. Their governments are focusing on promoting the ideal usage of antibiotics for livestock to ensure that there is no unadministered livestock consumption, thereby preventing health issues among people. With the expansion of the livestock industry in developing regions, the market is projected to have considerable growth.
Scope of the Veterinary Antimicrobial Susceptibility Testing Market Report
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Veterinary Antimicrobial Susceptibility Testing Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Product Type (Accessories & Consumables, Culture Media, and Disks & Plates), Animal Type (Livestock Animals [Poultry, Pigs, Cattle, and Others] and Companion Animals [Dogs, Cats, Horses, and Others]), and End-use (Veterinary Research Institutes, Veterinary Reference Labs, and Others)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
BD; Bioguard Corporation; Bio-Rad Laboratories, Inc.; Bruker Corporation; CONDALAB; Danaher; HiMedia Laboratories; Liofilchem S.r.l.; Synbiosis, A Division of Synoptics Ltd.; and Thermo Fisher Scientific Inc.
|
Veterinary Antimicrobial Susceptibility Testing Market Segment Insights
Product Type Segment Analysis
Based on product type, the veterinary antimicrobial susceptibility testing market is divided into accessories & consumables, culture media, and disks & plates. The disks & plates segment is projected to hold the major share of the market during the projection period, due to its extensive use in veterinary care. Methods such as disc diffusion are used for the classification of microorganisms in sensitive, intermediate, and resistant groups. The rising demand for veterinary antimicrobial susceptibility testing is expected to propel the growth of this segment.
Animal Type Segment Analysis
On the basis of animal type, the global market is bifurcated into livestock animals and companion animals. Livestock animals are further segregated into poultry, pigs, cattle, and others. Companion animals are divided into dogs, cats, horses, and others. The livestock animals segment is projected to register a high CAGR during the forecast period, owing to the increasing demand for meat-based products for human consumption. The meat required proper administration of antimicrobial drugs in order to restrain bacterial growth and ensure human health.
The companion animals segment is projected to register a considerable CAGR during the forecast period, due to the increasing trend of pet ownership. House pets are found with weaker immune systems compared to stray counterparts. Thus, house pets require extensive care and defense against bacterial diseases.
Veterinary healthcare professionals take the aid of antimicrobial susceptibility testing to find the nature of bacterial disease in pets and formulate the treatment accordingly. With rising instances of pet ownership in developed as well as developing countries, the veterinary antimicrobial susceptibility testing market is likely to have significant growth during the forecast period.
End-use Segment Analysis
On the basis of end-use, the veterinary antimicrobial susceptibility testing market is segmented into veterinary research institutes, veterinary reference labs, and others. The veterinary reference labs segment is anticipated to register a robust growth rate during the forecast period, owing to the advancements in animal healthcare infrastructure and the availability of technologically equipped facilities. The rising awareness of the health of animals in developing nations is leading to the setup of a large number of veterinary reference laboratories and is anticipated to propel this segment during the projection period.
Regional Outlook
In terms of region, the global veterinary antimicrobial susceptibility testing market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period, due to the presence of several major key players in this region. The high consumption of livestock food, particularly poultry meat, and beef, is one of the primary reasons for the extensive use of antibiotics in meat-based food here. In addition, the increasing awareness of maintaining the health of pet animals with proper administration of drugs is expected to contribute to the expansion of the market.
Asia Pacific is likely to witness substantial growth in the market during the forecast period, owing to the availability of a large livestock population in the region. The high demand for animal-based protein and milk products makes the use of antibiotics in animals. Rising economies such as India and China have a large consumption of milk-based and meat-based products and are anticipated to provide substantial growth opportunities for the market in the region.
Segments
The veterinary antimicrobial susceptibility testing market has been segmented on the basis of
Product Type
- Accessories & Consumables
- Culture Media
- Disks & Plates
Animal Type
- Livestock Animals
- Poultry
- Pigs
- Cattle
- Others
- Companion Animals
End-use
- Veterinary Research Institutes
- Veterinary Reference Labs
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
Competitive Landscape
Key players competing in the global veterinary antimicrobial susceptibility testing market are BD; Bioguard Corporation; Bio-Rad Laboratories, Inc.; Bruker Corporation; CONDALAB; Danaher; HiMedia Laboratories; Liofilchem S.r.l.; Synbiosis, A Division of Synoptics Ltd.; and Thermo Fisher Scientific Inc.
These companies adopt various development strategies such as partnerships, collaboration, mergers, product launches, acquisitions, and production expansion to boost global presence. They invest heavily in research & innovation for the development of new drugs and enhancing the testing systems. For instance,
-
In December 2021, Neogen Corporation, a global leader in food, beverage, and animal protein, announced its acquisition of Genetic Veterinary Sciences, Inc. The latter is a prominent supplier of genetic testing services for pet animals and is located in Spokane, Washington.
-
In February 2020, Becton, Dickinson, and Company, one of the major market players, collaborated with the Fleming Fund firm to aid underdeveloped and developing nations in managing the problem of antibiotic resistance. A budget of GBP 265 million has been allocated by Fleming Fund for the same.
Request For Customization
Enquiry Before Buying
Speak With Analyst
